trial

Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital

NCTId NCT07506070

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Not Yet Recruiting

Enrollment 160 (estimated)

Sponsored by The Royal Ottawa Mental Health Centre

Primary completion 2031-05-01

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Not Yet Recruiting

Enrollment

160 (estimated)

Study type

Interventional

Allocation

Model

Single Group

Masking

None

Start

2026-05-01

Primary completion

2031-05-01

Eligibility

ALL · 18 Years · 60 Years

Interventions & indications

Drugs

Action-Based Cognitive Remediation

Indications

Autism Spectrum Disorder Cognition Disorders Depression - Major Depressive Disorder Bipolar and Related Disorders Bipolar and Related Disorders Cognitive Dysfunction PTSD - Post Traumatic Stress Disorder Schizophrenia Combat Disorders Autism Spectrum Disorder Psychiatric Disorders Anxiety Disorders

Sites

0 total

Facts & assertions

4 sourced

Enrollment

160

Phase

Primary Completion Date

2031-05-01

Status

NOT_YET_RECRUITING

relationships

The graph out of here

drug

Action-Based Cognitive Remediation

drug

lead_sponsor

The Royal Ottawa Mental Health Centre

company

indication

Autism Spectrum Disorder

indication

Cognition Disorders

indication

Depression - Major Depressive Disorder

indication